NFKB1 and colitis: A previous study reported that opioid receptor agonist, BU08070, produced concentration-dependent inhibition of LPS-induced NF-κB activation, and exerted anti-inflammatory effect in mice with experimental colitis through activation of mu and delta opioid receptors (Zielińska et al., 2015).